欧洲建议批准更新Pfizer-BioNTEch疫苗和针对COVID新品种的现代疫苗。 Europe recommends approval for updated Pfizer-BioNTech and Moderna vaccines targeting new COVID variant.

欧洲药品机构委员会建议批准Pfizer-BioNTEch和现代公司针对LP.8.1变式的COVID-19最新疫苗。 The European Medicines Agency's committee has recommended approval for updated COVID-19 vaccines from Pfizer-BioNTech and Moderna targeting the LP.8.1 variant. 这两种疫苗都旨在预防6个月或6个月以上个人的COVID-19,如果欧洲联盟委员会批准,预计2025-2026年季节将可用。 Both vaccines aim to prevent COVID-19 in individuals six months and older and are expected to be available for the 2025-2026 season if the European Commission approves. 更新的疫苗显示,相对于目前的变种,免疫反应有所改善。 The updated vaccines show improved immune responses against current variants. 制造工作已经开始,经批准后装运就绪。 Manufacturing has already begun, with shipments ready upon authorization.